news

BenevolentAI hires new head of Cheminformatics from The Institute of Cancer Research

1
SHARES

BenevolentAI announced today it has hired Dr Nathan Brown, as its new Head of Cheminformatics following the promotion of Mark Davies…

Cheminformatics

BenevolentAI announced today it has hired Dr Nathan Brown BSc (Hons) FRSC, as its new Head of Cheminformatics following the promotion of Mark Davies from Head of Cheminformatics to Vice President of Biomedical Informatics earlier in the year.  

Dr Brown joined the Institute of Cancer Research (ICR), London in 2007 where he founded and led the new In Silico Medicinal Chemistry Group which focused on medicinal chemistry research towards novel cancer treatments. Dr Brown holds a degree in computing from Robert Gordon University, Aberdeen and conducted his doctoral research in the field of Cheminformatics at the University of Sheffield.  Following his PhD he was awarded a Marie Curie Fellowship for two years working with Avantium in Amsterdam and subsequently one of the first to be awarded a prestigious Presidential Research Fellowship for three years, by Professor Mark Fishman, Global Head of Research at the Novartis Institutes for BioMedical Research.

With extensive experience as a software designer Dr Brown has developed many novel algorithms to maximise the impact of the experimental data generated in medicinal chemistry and cancer biology. Furthermore Dr Brown is a recent recipient of the Corwin Hansch Award for contributions to computational chemistry. 

Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development. 

In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future. 

Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.

FREE DOWNLOAD HERE

Jackie Hunter, CEO of Benevolent Bío, the bioscience subsidiary of BenevolentAI, commented

“Nathan Brown is a recognised leader in the field of cheminformatics, molecular informatics and computational chemistry.  He has done exceptional work in the development of innovative anti-cancer therapies in an academic setting and his work is respected and well published.  We are delighted to have Nathan on board.”